Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore.
Biological activity
Butenolide
Cyclooxygenase
Furanone
Lactone
SAR
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
01 Jun 2019
01 Jun 2019
Historique:
received:
19
11
2018
revised:
09
02
2019
accepted:
07
03
2019
pubmed:
26
3
2019
medline:
29
5
2019
entrez:
26
3
2019
Statut:
ppublish
Résumé
Furanone, a five-membered heteroaromatic ring containing oxygen atom, is of immense pharmaceutical importance. Presence of this nucleus in biologically active compounds of natural and synthetic origin has made it an indispensable motif for design and development of new therapeutic agents. In recent years synthesis of furanone derivatives and exploring their therapeutic actions has been the prime interest amongst researchers. Furanone containing compounds cover numerous therapeutic categories viz. Analgesic and anti-inflammatory, anticancer, anticonvulsant, antibacterial and antifungal, antioxidant, antiulcer and anti-TB, etc. There is a need to couple recent work done with previously available information on furanone, a well acknowledged scaffold, to help scientists to develop novel and new furanone based therapeutic agents at a faster pace. This updated review highlights the worth of numerous therapeutically active furanone based compounds developed by the medicinal chemists. SAR studies have also been derived which may be useful for rational designing of furanone derivatives with improved therapeutic index.
Identifiants
pubmed: 30909021
pii: S0223-5234(19)30238-7
doi: 10.1016/j.ejmech.2019.03.021
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Inflammatory Agents, Non-Steroidal
0
Antifungal Agents
0
Antineoplastic Agents
0
Antiviral Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
66-92Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.